Dosing regimens of antibody-drug conjugate targeting delta-like ligand 3 for treatment of neuroendocrine neoplasms

TW202635352APending Publication Date: 2026-09-01ZAI LAB (SHANGHAI) CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141293
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-30
Filing Date
2025-10-23
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074490_001
    Figure TWG2TA001074490_001
  • Figure TWG2TA001074490_002
    Figure TWG2TA001074490_002
  • Figure TWG2TA001074490_003
    Figure TWG2TA001074490_003
Patent Text Reader

Abstract

The present invention relates to dosing regimens of antibody-drug conjugate targeting δ-like ligand
Need to check novelty before this filing date? Find Prior Art